Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:16:44.634Z.
Calculation as of: 2026-10-06T16:16:44.634Z.
Quote observation: 2026-10-06T16:13:57.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1e37222dd90dbab5e03bfa1bbf20eaf6e61690ec1e62f49524765e66f30de265
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Filana Therapeutics, Inc.
Market Cap
$40.67M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$40.28M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.88M
Free Cash Flow Yield
N/A
TTM Avg
18.27%
3Y Avg
9.27%
5Y Avg
7.40%
Market Cap
$42.61M
Free Cash Flow Yield
1.85%
TTM Avg
1.42%
3Y Avg
1.97%
5Y Avg
1.97%
Market Cap
$38.35M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$43.14M
Free Cash Flow Yield
N/A
TTM Avg
8.38%
3Y Avg
7.29%
5Y Avg
5.95%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | $40.67M | N/A | N/A | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $39.96M | N/A | 4.03% | 3.27% | 3.27% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.88M | N/A | 18.27% | 9.27% | 7.40% |
| Precipio, Inc. (PRPO)vs › | $42.61M | 1.85% | 1.42% | 1.97% | 1.97% |
| Incannex Healthcare Limited (IXHL)vs › | $38.35M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $43.14M | N/A | 8.38% | 7.29% | 5.95% |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.97M | N/A | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $44.05M | N/A | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $44.35M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
